Bausch Health Companies is a drug manufacturers - specialty & generic business based in the US. Bausch Health Companies shares (BHC) are listed on the NYSE and all prices are listed in US Dollars. Bausch Health Companies employs 20,270 staff and has a trailing 12-month revenue of around $9 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $7.57 |
|---|---|
| 52-week range | $6.05 - $11.46 |
| 50-day moving average | $6.79 |
| 200-day moving average | $7.82 |
| Wall St. target price | $9.57 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.24 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $7.57 from 2024-07-23
| 1 week (2024-07-19) | -0.39% |
|---|---|
| 1 month (2024-06-26) | 11.49% |
| 3 months (2024-04-26) | -13.09% |
| 6 months (2024-01-26) | -7.46% |
| 1 year (2023-07-26) | -19.98% |
|---|---|
| 2 years (2022-07-26) | -13.39% |
| 3 years (2021-07-26) | 28.63 |
| 5 years (2019-07-26) | 23.81 |
Valuing Bausch Health Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bausch Health Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bausch Health Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.6315. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bausch Health Companies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Bausch Health Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3 billion.
The EBITDA is a measure of a Bausch Health Companies's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $9 billion |
|---|---|
| Operating margin TTM | 13.89% |
| Gross profit TTM | $5.8 billion |
| Return on assets TTM | 4.04% |
| Return on equity TTM | -686.52% |
| Profit margin | -5.08% |
| Book value | $-3.04 |
| Market Capitalization | $2.8 billion |
TTM: trailing 12 months
We're not expecting Bausch Health Companies to pay a dividend over the next 12 months.
Bausch Health Companies's shares were split on a 2:1 basis on 15 October 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bausch Health Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bausch Health Companies shares which in turn could have impacted Bausch Health Companies's share price.
Over the last 12 months, Bausch Health Companies's shares have ranged in value from as little as $6.05 up to $11.46. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bausch Health Companies's is 0.77. This would suggest that Bausch Health Companies's shares are less volatile than average (for this exchange).
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.